Health Care & Life Sciences » Biotechnology | Argos Therapeutics Inc.

Argos Therapeutics Inc. | Mutual Funds

Mutual Funds that own Argos Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Meeder Spectrum Fund
5,671
0.05%
358
0%
06/29/2018
2,553
0.02%
0
0%
09/05/2018
Illinois State Board of Investment
45
0%
45
0%
06/30/2016
Illinois State Board of Investment
45
0%
45
0%
06/30/2016
Wasatch Ultra Growth Fund
0
0%
-25,679
0%
03/31/2018
CI Global Health Sciences Corporate Class
0
0%
-8,625
0%
06/30/2017

About Argos Therapeutics

View Profile
Address
4233 Technology Drive
Durham North Carolina 27704
United States
Employees -
Website http://www.argostherapeutics.com
Updated 09/14/2018
Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.